Silence Therapeutics
London · Founded 1999
About Silence Therapeutics
Silence Therapeutics is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.
Company Facts
- Founded: 1999
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $248.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2024)
- Ticker: lse:SLN
- Website: silence-therapeutics.com
- Phone: +44 020-3700-9711
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/silence-therapeutics-130545 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.